J. Goldman & Co’s VIVEVE MED INC VIVE Stock Holding History

J. Goldman & Co’s Portfolio VIVE Stock Details VIVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-306	Closed	-$116K	–	386
2019 Q2	$116K	Sell	306 -232	-43%	-$126K	0.01%	252
2019 Q1	$505K	Buy	538 +193	+56%	+$205K	0.03%	233
2018 Q4	$362K	Buy	345 +254	+279%	+$610K	0.03%	213
2018 Q3	$244K	Sell	91 -130	-59%	-$368K	0.02%	240
2018 Q2	$601K	Sell	221 -203	-48%	-$585K	0.03%	279
2018 Q1	$1.55M	Buy	424 +117	+38%	+$509K	0.07%	234
2017 Q4	$1.53M	Buy	307 +127	+71%	+$661K	0.08%	208
2017 Q3	$943K	Buy	+180	New	+$1.11M	0.05%	241

Other funds holding VIVE

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

J. Goldman & Co's VIVE Position: Q3 2019 in Review

J. Goldman & Co sold out of VIVEVE MED INC (VIVE) in Q3 2019, closing a stake of 306 shares — an estimated $116K sold.

J. Goldman & Co first reported a position in VIVE in Q3 2017 and held it in 8 quarters. The position peaked at $1.55M in Q1 2018. 11 funds tracked by Wall St. Rank hold VIVE as of Q3 2019.

J. Goldman & Co reported no remaining VIVEVE MED INC position as of Q3 2019 after selling out during the quarter.
J. Goldman & Co sold 306 VIVEVE MED INC shares in Q3 2019, an estimated $116K.
J. Goldman & Co first reported a position in VIVEVE MED INC in Q3 2017 and held it in 8 quarters.
J. Goldman & Co's VIVEVE MED INC position peaked at $1.55M in Q1 2018.
11 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q3 2019.

Based on J. Goldman & Co's 13F filing for Q3 2019, filed 14 Nov 2019.